Warning: count(): Parameter must be an array or an object that implements Countable in /home/hmc/public_html/wp-content/plugins/formcraft3/formcraft-main.php on line 1013
Welcome to Endocardiology Symposium Post Activity Assessment
Thank you and congratulations for attending this educational activity. Remember, continuous professional development is key to success and professional excellence.
This test is composed of 26 questions based on the information provided to you during the activity. You will have two attempts to complete this test. The 30 minutes which will allow enough time to search for the correct answers.
You must exceed the passing score (60%) in order to receive your certificate.
Endocrinology and cardiology Symposium
Quiz Summary
0 of 26 questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
0 of 26 questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
- Clinical 0%
- Pharmacy 0%
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- Current
- Review
- Answered
- Correct
- Incorrect
-
Question 1 of 26
1. Question
Select the patients that are unlikely to benefit from indefinite anticoagulation
CorrectIncorrect -
Question 2 of 26
2. Question
Warfarin is stopped for 5 days before surgery. INR at the time of surgery should be ≥ 1.5 for patients at significant risk of an embolic event
CorrectIncorrect -
Question 3 of 26
3. Question
All the below are risk factors for VTE recurrence except:
CorrectIncorrect -
Question 4 of 26
4. Question
To determine the need for warfarin hold and bridging, assess the patient’s risk of bleeding like
CorrectIncorrect -
Question 5 of 26
5. Question
In making the decision to indefinitely Anticoagulate, one should consider
CorrectIncorrect -
Question 6 of 26
6. Question
The risk of thrombosis is high with all of these groups except:
CorrectIncorrect -
Question 7 of 26
7. Question
Dimer should be tested during the acute phase of the VTE to help decide on the duration of the Anticoagulation
CorrectIncorrect -
Question 8 of 26
8. Question
Which of these statements is incorrect ?
CorrectIncorrect -
Question 9 of 26
9. Question
Aspirin can be offered for patients who decline Anticoagulation
CorrectIncorrect -
Question 10 of 26
10. Question
The monitoring parameter when starting heparin include:
CorrectIncorrect -
Question 11 of 26
11. Question
Counter-regulatory hormones increase glycogenesis and improves insulin sensitivity
CorrectIncorrect -
Question 12 of 26
12. Question
Is concomitant bleeding a contraindication to the use of anticoagulant treatment in patients with CVT?
CorrectIncorrect -
Question 13 of 26
13. Question
Blood sugar target for perioperative non-cardiac non ICU patients ranges between 6.7 and 8.3 mmol/l
CorrectIncorrect -
Question 14 of 26
14. Question
What is the preferred agent in treatment of acute CVT?
CorrectIncorrect -
Question 15 of 26
15. Question
Which of this statement is the best answer:
CorrectIncorrect -
Question 16 of 26
16. Question
Patients with confirmed SVT within 3 cm of the saphenofemoral junction should be considered for:
CorrectIncorrect -
Question 17 of 26
17. Question
F.J. is a 40-year-old male with a history of diabetes mellitus type 2 for 10 years, currently he is on glargine 32 units qpm , insulin Aspart 10 units tid.ac . His latest HgbA1c 1 month ago is 7.1 his self-monitoring glucose record is generally acceptable with no episode of hypoglycemia during the last months.
He is scheduled for cholecystectomy tomorrow morning
F.J. had forgotten what does the anesthetist told him about the day before surgery insulin regimen and came to you for an adviceCorrectIncorrect -
Question 18 of 26
18. Question
What is the proposed anticoagulation treatment duration for patient with unprovoked CVT:
CorrectIncorrect -
Question 19 of 26
19. Question
Dapagliflozin/Empagliflozin/Canagliflozin exert their effect by blocking sodium glucose co-transporters (SGLTs) type 1 & 2 in intestinal mucosa and kidneys, thus prevent reabsorption of glucose
CorrectIncorrect -
Question 20 of 26
20. Question
Which of the following cases doesn’t require thrombophilia screen:
CorrectIncorrect -
Question 21 of 26
21. Question
The maximum HbA1c reduction exerted by SGLT2 inhibitors is around:
CorrectIncorrect -
Question 22 of 26
22. Question
In the EMPA-REG OUTCOME ClinicalTrial, compared to placebo:
CorrectIncorrect -
Question 23 of 26
23. Question
SGLT-2 inhibitors are associated with Hyperglycemic DKA and ketosis
CorrectIncorrect -
Question 24 of 26
24. Question
Due to their novel insulin independent mechanism, SGLT2 inhibitors are recommended as initial therapy for the majority of patients with type 2 diabetes
CorrectIncorrect -
Question 25 of 26
25. Question
Which statement is correct
CorrectIncorrect -
Question 26 of 26
26. Question
In most instances in the hospital setting,insulin is the preferred treatment for glycemic control
CorrectIncorrect